Email this article to a friend
Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor
-
* Corresponding author: Mef Nilbert mef.nilbert@med.lu.se
BMC Clinical Pathology 2009, 9:8 doi:10.1186/1472-6890-9-8